Table of Contents
Is regorafenib available on the NHS?
Regorafenib (Stivarga) is available on the NHS. It is a possible treatment for advanced hepatocellular carcinoma (liver cancer) in adults who have had sorafenib and have: a tumour that can’t be removed by surgery (unresectable)
How long does stivarga extend life?
Improvement in Overall Survival Patients taking STIVARGA (379) lived a median of 10.6 months compared to those taking placebo (194) who lived a median of 7.8 months.
Is regorafenib an immunotherapy?
Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth.
Is regorafenib a targeted therapy?
Regorafenib is a type of targeted therapy called a tyrosine kinase inhibitor. A kinase is an enzyme that promotes cell growth. There are many types of kinases, which control different phases of cell growth.
How much does regorafenib cost?
Regorafenib is dosed in 40-mg tablets, and the recommended starting dose is 160 mg. The AWP is $147.26 per 40-mg tablet.
Is regorafenib available in UK?
“There are also very few effective treatments so the decision to approve regorafenib for routine use in England and Wales is a welcome step forward. Access to the drug will potentially provide patients with valuable extra time with their loved ones.”
Is regorafenib a chemotherapy?
Regorafenib is the generic name for the trade name chemotherapy drug Stivarga®. In some cases, health care professionals may use the trade name Stivarga® when referring to the generic drug name regorafenib.
What are the side effects of Pembrolizumab?
Common side effects of KEYTRUDA when used alone include: feeling tired, pain, including pain in muscles, rash, diarrhea, fever, cough, decreased appetite, itching, shortness of breath, constipation, bones or joints and stomach-area (abdominal) pain, nausea, and low levels of thyroid hormone.
How long can you take regorafenib?
How long will I be taking STIVARGA? The recommended dose of STIVARGA is 160 mg (four 40-mg tablets) every day for 3 weeks, followed by a 1-week break. This is 1 cycle of treatment. Your doctor may stop your treatment or change the dose.
Is Abraxane more expensive than Taxol?
And, in at least one way, Abraxane is a breakthrough: it costs about 25 times as much as a generic version of the older medicine, which is best known by its brand name, Taxol. Because of the odd economics of the cancer drug market, though, Abraxane’s price does not seem to be hurting its popularity.
How safe is regorafenib in treatment-refractory colorectal cancer?
Background: In the phase III CORRECT trial, regorafenib significantly improved survival in treatment-refractory metastatic colorectal cancer (mCRC). The CONSIGN study was designed to further characterize regorafenib safety and allow patients access to regorafenib before market authorization.
Is regorafenib a multiple kinase inhibitor?
Regorafenib (Stivarga®) is an oral small-molecule multiple kinase inhibitor. It is indicated worldwide for patients with metastatic colorectal cancer (mCRC). In the EU and USA it is indicated for patients with mCRC who have been previously treated with, or are not considered candidates fo …
Is it safe to take regorafenib with nivolumab?
Before a treatment can be approved for people to take, researchers do clinical trials to better understand its safety and how it works. In this trial, the researchers want to learn about regorafenib taken together with nivolumab in a small number of participants with different types of tumors.
What is the dose of regorafenib for the biliary tract?
The biliary tract includes gall bladder and bile ducts. The trial will include about 200 participants who are at least 18 years old. All of the participants will take 90 mg of regorafenib as a tablet by mouth. The dose of regorafenib can be adjusted up to 120 mg or down to 60 mg by the doctor based on how well a participant tolerates treatment.